Annual report pursuant to Section 13 and 15(d)

Note 2 - Summary of Significant Accounting Policies - Restatement of Previously Issued Consolidated Financial Statements (Details)

v3.21.1
Note 2 - Summary of Significant Accounting Policies - Restatement of Previously Issued Consolidated Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended 8 Months Ended 9 Months Ended 11 Months Ended 12 Months Ended
Dec. 05, 2018
Jan. 31, 2019
Jul. 31, 2020
Apr. 30, 2020
Jan. 31, 2020
Jul. 31, 2019
Apr. 30, 2019
Apr. 30, 2019
Apr. 30, 2020
Jul. 31, 2019
Jul. 31, 2020
Oct. 31, 2019
Oct. 31, 2020
Warrant liability   $ 29,040 $ 6,639 $ 3,905 $ 7,160 $ 13,018 $ 17,574 $ 17,574 $ 3,905 $ 13,018 $ 6,639 $ 6,769 $ 7,031
Total liabilities   492,875 498,391 520,471 521,796 537,640 501,750 501,750 520,471 537,640 498,391 529,319 481,648
Additional paid-in capital   246,463 360,434 359,077 357,694 354,594 275,584 275,584 359,077 354,594 360,434 356,227 367,681
Accumulated deficit   (28,336) (97,190) (97,438) (41,724) (45,437) (52,755) (52,755) (97,438) (45,437) (97,190) (38,589) (99,840)
Total stockholders' equity   217,573 264,126 258,701 317,216 302,721 220,926 220,926 258,701 302,721 264,126 317,045 267,110
Change in fair value of warrant liabilities $ 0 (2,522) (2,734) 3,254 (391) 4,556 (14,774) (17,296) 2,864 (12,740) 130 (6,491) (261)
Total other income (expense) (18,033) (8,103) (11,062) (5,477) (9,825) (5,259) (24,072) (32,175) (15,301) (37,434) (26,502) (41,324) (34,500)
Income (loss) before income taxes (26,767) (8,917) (215) (57,935) (4,284) 5,396 (22,847) (31,764) (62,218) (26,368) (62,432) (19,706) (66,228)
Net loss $ (22,575) $ (6,152) $ 247 $ (55,714) $ (3,137) $ 7,318 $ (24,419) $ (30,571) $ (58,850) $ (23,253) $ (58,603) $ (16,403) $ (61,251)
Basic (in dollars per share) $ (3.00) $ (0.22) $ (0.00) $ (1.06) $ (0.07) $ 0.14 $ (0.85) $ (1.08) $ (1.13) $ (0.66) $ (1.14) $ (0.43) $ (1.20)
Diluted (in dollars per share) $ (3.00) $ (0.22) $ (0.00) $ (1.06) $ (0.07) $ 0.13 $ (0.85) $ (1.08) $ (1.13) $ (0.66) $ (1.14) $ (0.43) $ (1.20)
Increase (decrease) in fair value of warrant liabilities $ (0) $ 2,522 $ 2,734 $ (3,254) $ 391 $ (4,556) $ 14,774 $ 17,296 $ (2,864) $ 12,740 $ (130) $ 6,491 $ 261
Net cash provided by operating activities   (12,949)     1,814     (4,090) 26,987 1,425 53,484 22,777 78,970
Previously Reported [Member]                          
Warrant liability   0 0 0 0 0 0 0 0 0 0 0 0
Total liabilities   463,835 491,752 516,566 514,636 524,622 484,176 484,176 516,566 524,622 491,752 522,550 474,617
Additional paid-in capital   261,808 354,696 353,339 351,956 348,856 269,846 269,846 353,339 348,856 354,696 350,489 361,943
Accumulated deficit   (14,641) (84,814) (87,795) (28,827) (26,682) (29,444) (29,444) (87,795) (26,682) (84,814) (26,081) (87,071)
Total stockholders' equity 5,000 246,613 270,765 262,606 324,376 315,739 238,500 238,500 262,606 315,739 270,765 323,815 274,141
Change in fair value of warrant liabilities   0 0 0 0 0 0 0 0 0 0 0 0
Total other income (expense)   (5,581) (8,328) (8,731) (9,434) (9,815) (9,298) (14,879) (18,165) (24,694) (26,632) (34,833) (34,239)
Income (loss) before income taxes   (6,395) 2,519 (61,189) (3,893) 840 (8,073) (14,468) (65,082) (13,628) (62,562) (13,215) (65,967)
Net loss   $ (3,630) $ 2,981 $ (58,968) $ (2,746) $ 2,762 $ (9,645) $ (13,275) $ (61,714) $ (10,513) $ (58,733) $ (9,912) $ (60,990)
Basic (in dollars per share)   $ (0.14) $ 0.05 $ (1.13) $ (0.06) $ 0.05 $ (0.35) $ (0.48) $ (1.19) $ (0.31) $ (1.14) $ (0.28) $ (1.19)
Diluted (in dollars per share)   $ (0.14) $ 0.04 $ (1.13) $ (0.06) $ 0.05 $ (0.35) $ (0.48) $ (1.19) $ (0.31) $ (1.14) $ (0.28) $ (1.19)
Increase (decrease) in fair value of warrant liabilities   $ (0) $ (0) $ (0) $ (0) $ (0) $ (0) $ (0) $ (0) $ (0) $ (0) $ (0) $ (0)
Net cash provided by operating activities   (12,949)     1,814     (4,090) 26,987 1,425 53,484 22,777 78,970
Revision of Prior Period, Adjustment [Member]                          
Warrant liability   29,040 6,639 3,905 7,160 13,018 17,574 17,574 3,905 13,018 6,639 6,769 7,031
Total liabilities   29,040 6,639 3,905 7,160 13,018 17,574 17,574 3,905 13,018 6,639 6,769 7,031
Additional paid-in capital   (15,345) 5,738 5,738 5,738 5,738 5,738 5,738 5,738 5,738 5,738 5,738 5,738
Accumulated deficit   (13,695) (12,376) (9,643) (12,897) (18,755) (23,311) (23,311) (9,643) (18,755) (12,376) (12,508) (12,769)
Total stockholders' equity $ (26,519) (29,040) (6,639) (3,905) (7,160) (13,018) (17,574) (17,574) (3,905) (13,018) (6,639) (6,769) (7,031)
Change in fair value of warrant liabilities   (2,522) (2,734) 3,254 (391) 4,556 (14,774) (17,296) 2,864 (12,740) 130 (6,491) (261)
Total other income (expense)   (2,522) (2,734) 3,254 (391) 4,556 (14,774) (17,296) 2,864 (12,740) 130 (6,491) (261)
Income (loss) before income taxes   (2,522) (2,734) 3,254 (391) 4,556 (14,774) (17,296) 2,864 (12,740) 130 (6,491) (261)
Net loss   $ (2,522) $ (2,734) $ 3,254 $ (391) $ 4,556 $ (14,774) $ (17,296) $ 2,864 $ (12,740) $ 130 $ (6,491) $ (261)
Basic (in dollars per share)   $ (0.08) $ (0.05) $ 0.07 $ (0.01) $ 0.09 $ (0.50) $ (0.60) $ 0.06 $ (0.35) $ 0.00 $ (0.15) $ (0.01)
Diluted (in dollars per share)   $ (0.08) $ (0.04) $ 0.07 $ (0.01) $ 0.08 $ (0.50) $ (0.60) $ 0.06 $ (0.35) $ 0.00 $ (0.15) $ (0.01)
Increase (decrease) in fair value of warrant liabilities   $ 2,522 $ 2,734 $ (3,254) $ 391 $ (4,556) $ 14,774 $ 17,296 $ (2,864) $ 12,740 $ (130) $ 6,491 $ 261
Net cash provided by operating activities   $ 0     $ 0     $ 0 $ 0 $ 0 $ 0 $ 0 $ 0